carbapenems has been researched along with Diabetic Feet in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Arapi, B; Baghaki, S; Balkan, II; Budak, B; Caglar, B; Can, G; Cetinkale, O; Gonen, MS; Karaali, R; Kurt, AF; Ozdemir, M; Saltoglu, N; Seker, A; Surme, S; Togluk-Yigitoglu, E; Vatan, A | 1 |
| Cen, H; Zhang, L | 1 |
| Bu, X; Deng, W; Ding, M; Guo, X; Ju, S; Li, Q; Li, X; Li, Y; Liu, Y; Qi, X; Yu, Z; Yuan, G | 1 |
| Borghi, M; Bueno Freitas, L; Cruz Spano, L; Pinto Schuenck, R; Santos Almeida, M; Soares Jardim Lacerda Batista, J; Tonini, MA | 1 |
| Barajas-Nava, LA; Bonfill Cosp, X; Gianneo, OD; Lipsky, BA; Selva Olid, A; Solà, I | 1 |
| Naser, N; Shliapnikov, SA | 1 |
| Citron, DM; Fernandez, HT; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA | 1 |
2 review(s) available for carbapenems and Diabetic Feet
| Article | Year |
|---|---|
Systemic antibiotics for treating diabetic foot infections.
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Diabetic Foot; Fluoroquinolones; Humans; Penicillins; Randomized Controlled Trials as Topic | 2015 |
[Surgical infection of soft tissue--a problem of adequate antibiotic therapy].
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Diabetic Foot; Drug Therapy, Combination; Fasciitis, Necrotizing; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Soft Tissue Infections; Species Specificity; Surgical Wound Infection | 2003 |
5 other study(ies) available for carbapenems and Diabetic Feet
| Article | Year |
|---|---|
Changing Bacterial Etiology and Antimicrobial Resistance Profiles as Prognostic Determinants of Diabetic Foot Infections: A Ten-Year Retrospective Cohort Study.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteria; Carbapenems; Cohort Studies; Diabetes Mellitus; Diabetic Foot; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Prognosis; Pseudomonas aeruginosa; Reinfection; Retrospective Studies | 2022 |
Management of carbapenem-resistant Klebsiella pneumoniae infection in a patient with diabetic foot ulcer and necrotizing soft tissue infection, bacteremia and lung infection: A case report.
Topics: Aged; Amputation, Surgical; Bacteremia; Carbapenems; Debridement; Diabetic Foot; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Leg; Male; Necrosis; Negative-Pressure Wound Therapy; Pneumonia, Bacterial; Soft Tissue Infections | 2020 |
Microbiological profile and clinical characteristics of diabetic foot infection in northern China: a retrospective multicentre survey in the Beijing area.
Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; China; Diabetic Foot; Enterobacteriaceae; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Surveys and Questionnaires; Tertiary Care Centers | 2018 |
Carbapenem-susceptible Escherichia coli ST3901 carrying mcr-1 and bla
Topics: beta-Lactamases; Brazil; Carbapenems; Diabetic Foot; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Male; Middle Aged | 2018 |
In vitro activities of doripenem and six comparator drugs against 423 aerobic and anaerobic bacterial isolates from infected diabetic foot wounds.
Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Diabetic Foot; Doripenem; Humans; Microbial Sensitivity Tests | 2008 |